Researchers from Miguel Hernández University of Elche (UMH) in Spain have identified an effective strategy to reduce structural liver damage and improve hepatic vascular function in cirrhosis.

Hepatitis C is a tiny virus with a significant impact. It's a small RNA virus that spreads through the blood and infects the liver. Even though today's medicines can cure it, hepatitis C remains a ...

At a Bengaluru-based therapy centre, a middle-aged man with alcohol dependence showed marked improvement in foot drop & liver ...

Santa Barbara Cottage Hospital (SBCH) is now offering histotripsy, an innovative, non-invasive treatment that uses focused ultrasound energy to precisely ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

Sagimet Biosciences Inc. stock rated Strong Buy on promising drug data and pipeline growth in acne and MASH. Click for this ...

For these women, menopause wasn’t to be experienced quietly. With the help of their doctors and the right treatment option, ...

Using electronic health record data from more than 12,000 PBC patients, investigators found that UDCA use was associated with ...

Altimmune said on Friday its experimental liver disease drug led to weight loss and improved markers for scarring and health of the organ based on non-invasive tests after 48 weeks of treatment in a ...

The best-case scenario on alcohol related liver disease is a remission from physical symptoms and a restoration of liver function to a level where the patients can live a life as close to normal as ...

Altimmune has shared an update on the metabolic dysfunction-associated steatohepatitis (MASH) study that sank its stock in June. The 48-week readout linked the top dose of the GLP-1/glucagon dual ...

Altimmune said on Friday its experimental liver disease drug improved signs of scarring and ‍health of the organ after 48 weeks of treatment in a mid-stage study, sending the company's shares up more ...